Carlsen; Peter Niels

Patent Applications and Registrations

Patent applications and USPTO patent grants for Carlsen; Peter Niels.The latest application filed is for "combination therapy comprising a2a/a2b inhibitors, pd-1/pd-l1 inhibitors, and anti-cd73 antibodies".

Company Profile

2.1.8

Carlsen; Peter Niels - Claymont DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Therapy Comprising A2a/a2b Inhibitors, Pd-1/pd-l1 Inhibitors, And Anti-cd73 Antibodies App 20220233529 - Wang; Hui ; et al.	2022-07-28
Pyrrole Tricyclic Compounds As A2a / A2b Inhibitors App 20220213112 - Wang; Xiaozhao ; et al.	2022-07-07
C10-Cyclic Substituted 13-Membered Macrolides and Uses Thereof App 20220177508 - Clark; Roger B. ; et al.	2022-06-09
Fused Pyrazine Derivatives As A2a / A2b Inhibitors App 20220135570 - Wang; Xiaozhao ; et al.	2022-05-05
Pyrrole tricyclic compounds as A2A / A2B inhibitors Grant 11,220,510 - Wang , et al. January 11, 2	2022-01-11
Cd73 Inhibitor And A2a/a2b Adenosine Receptor Inhibitor Combination Therapy App 20210230294 - Nastri; Horacio G. ; et al.	2021-07-29
Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors App 20210205311 - Wang; Hui ; et al.	2021-07-08
Fused Pyrazine Derivatives As A2a / A2b Inhibitors App 20200031835 - Wang; Xiaozhao ; et al.	2020-01-30
Pyrrole Tricyclic Compounds As A2a / A2b Inhibitors App 20190337957 - Wang; Xiaozhao ; et al.	2019-11-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.